-
Taxonomy & unit
-
us-gaap: CAD and USD
-
Description
-
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
-
Summary
-
Intellipharmaceutics International Inc. quarterly Liabilities, Current history and growth rate from Q4 2015 to Q4 2018.
- Intellipharmaceutics International Inc. Liabilities, Current for the quarter ending November 30, 2018 was CA$5.31M, a 14.2% increase year-over-year.
Liabilities, Current, Quarterly (CAD)
Liabilities, Current, YoY Quarterly Growth (%)